Therefore, our data are in line with these studies, as we showed that high post-treatment vinculin expression, in both ER+ and HER2+ cancer cells (Figures 7A, B, 8A, B), correlates with decreased potential for detachment and, therefore, migration upon ECM from the yielded evidence of detachment, spreading and cell stiffness. This evidence concerns the gene ESR1 and cancer.